BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 15153889)

  • 1. Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study.
    Hundley JL; Yosipovitch G
    J Am Acad Dermatol; 2004 Jun; 50(6):889-91. PubMed ID: 15153889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mirtazapine: a newer antidepressant.
    Hartmann PM
    Am Fam Physician; 1999 Jan; 59(1):159-61. PubMed ID: 9917581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mirtazapine for treatment-resistant depression: a preliminary report.
    Wan DD; Kundhur D; Solomons K; Yatham LN; Lam RW
    J Psychiatry Neurosci; 2003 Jan; 28(1):55-9. PubMed ID: 12587851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative efficacy of remeron (mirtazapine) and amitriptyline in treatment of patients with depression of moderate intensity].
    Iakovlev VA; Belinskiĭ AV; Dorovskikh IV; Zhbrykunov VL
    Voen Med Zh; 2000 Oct; 321(10):27-9. PubMed ID: 11334006
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of mirtazapine in clinically relevant subgroups of depressed patients.
    Nutt DJ
    Depress Anxiety; 1998; 7 Suppl 1():7-10. PubMed ID: 9597345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of mirtazapine in patients with chronic pain and concomitant depression.
    Freynhagen R; Muth-Selbach U; Lipfert P; Stevens MF; Zacharowski K; Tölle TR; von Giesen HJ
    Curr Med Res Opin; 2006 Feb; 22(2):257-64. PubMed ID: 16466597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacologic profile of mirtazapine.
    de Boer T
    J Clin Psychiatry; 1996; 57 Suppl 4():19-25. PubMed ID: 8636062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open trial of mirtazapine in patients with fibromyalgia.
    Samborski W; Lezanska-Szpera M; Rybakowski JK
    Pharmacopsychiatry; 2004 Jul; 37(4):168-70. PubMed ID: 15467973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mirtazapine (Remeron) as treatment for non-mechanical vomiting after gastric bypass.
    Teixeira FV; Novaretti TM; Pilon B; Pereira PG; Breda MF
    Obes Surg; 2005 May; 15(5):707-9. PubMed ID: 15946465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability and safety aspects of mirtazapine.
    Nutt DJ
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S37-41. PubMed ID: 12404669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interference in the serotoninergic and noradrenergic system. Faster out of depression].
    MMW Fortschr Med; 2001 Nov; 143(44):57. PubMed ID: 11732403
    [No Abstract]   [Full Text] [Related]  

  • 12. Mirtazapine for pruritus.
    Davis MP; Frandsen JL; Walsh D; Andresen S; Taylor S
    J Pain Symptom Manage; 2003 Mar; 25(3):288-91. PubMed ID: 12614964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More evidence on additive antipsychotic effect of adjunctive mirtazapine in schizophrenia: an extension phase of a randomized controlled trial.
    Terevnikov V; Stenberg JH; Joffe M; Tiihonen J; Burkin M; Tchoukhine E; Joffe G
    Hum Psychopharmacol; 2010 Aug; 25(6):431-8. PubMed ID: 20737516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mirtazapine-induced akathisia.
    Gulsun M; Doruk A
    J Clin Psychopharmacol; 2008 Aug; 28(4):467. PubMed ID: 18626283
    [No Abstract]   [Full Text] [Related]  

  • 15. Dysthymic disorder: treatment with mirtazapine.
    Dunner DL; Hendrickson HE; Bea C; Budech CB; O'Connor E
    Depress Anxiety; 1999; 10(2):68-72. PubMed ID: 10569129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.
    Koran LM; Gamel NN; Choung HW; Smith EH; Aboujaoude EN
    J Clin Psychiatry; 2005 Apr; 66(4):515-20. PubMed ID: 15816795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of mirtazapine in a patient with chronic pain.
    Brannon GE; Stone KD
    J Pain Symptom Manage; 1999 Nov; 18(5):382-5. PubMed ID: 10584463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective open-label pilot trial of mirtazapine in children and adolescents with social phobia.
    Mrakotsky C; Masek B; Biederman J; Raches D; Hsin O; Forbes P; de Moor C; DeMaso DR; Gonzalez-Heydrich J
    J Anxiety Disord; 2008; 22(1):88-97. PubMed ID: 17419001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Add-on mirtazapine enhances effects on cognition in schizophrenic patients under stabilized treatment with clozapine.
    Delle Chiaie R; Salviati M; Fiorentini S; Biondi M
    Exp Clin Psychopharmacol; 2007 Dec; 15(6):563-8. PubMed ID: 18179309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alleviating the itch-scratch cycle in atopic dermatitis.
    Mahtani R; Parekh N; Mangat I; Bhalerao S
    Psychosomatics; 2005; 46(4):373-4. PubMed ID: 16000683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.